Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer disease

Neurology

Volumn 83, Issue 8, 2014, Pages 710-717

  McDade, Eric ^a   Kim, Albert ^a,b   James, Jeffrey ^a   Sheu, Lei K ^a   Kuan, Dora Chieh Hsin ^a   Minhas, Davneet ^a   Gianaros, Peter J ^a   Ikonomovic, Snezana ^a   Lopez, Oscar ^a   Snitz, Beth ^a   Price, Julie ^a   Becker, Jim ^a   Mathis, Chet ^a   Klunk, William ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ADULT; ALZHEIMER DISEASE; ARTICLE; ATTENTION; AUTOSOMAL DOMINANT DISORDER; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; EXECUTIVE FUNCTION; FEMALE; HUMAN; MALE; MEMORY; MIDDLE TEMPORAL GYRUS; MOTOR CORTEX; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OCCIPITAL CORTEX; PARIETAL LOBE; PREFRONTAL CORTEX; SENSORY CORTEX; TEMPORAL CORTEX; BRAIN CIRCULATION; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PATHOLOGY; PERFUSION; PHYSIOLOGY; PROCEDURES;

ADULT; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PERFUSION; PRESENILIN-1;

EID: 84920618777     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000721     Document Type: Article

References (29)

1. Smith EE, Greenberg SM. Beta-amyloid, blood vessels, and brain function. Stroke 2009;40:2601-2606.
2. Thal DR, Capetillo-Zarate E, Larionov S, Staufenbiel M, Zurbruegg S, Beckmann N. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances. Neurobiol Aging 2009;30:1936-1948.
3. Princz-Kranz FL, Mueggler T, Knobloch M, Nitsch RM, Rudin M. Vascular response to acetazolamide decreases as a function of age in the arcA beta mouse model of cerebral amyloidosis. Neurobiol Dis 2010;40:284-292.
4. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 2011;12:723-738.
5. Dumas A, Dierksen GA, Edip Gurol M, et al. Functional MRI detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol 2012;72:76-81.
6. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension. Stroke 2008;39:349-354.
7. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009;250:856-866.
8. Morris J. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
10. Jack CR, Bernstein MA, Fox NC, et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 2008;27:685-691.
11. Cohen AD, Price JC, Weissfeld LA, et al. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: An example of brain reserve. J Neurosci 2009;29:14770-14778.
12. Lopresti BJ, Klunk WE, Mathis CA, et al. Simplified quantification of Pittsburgh compound B amyloid imaging PET studies: A comparative analysis. J Nucl Med 2005;46: 1959-1972.
13. Jennings JR, Heim AF, Kuan DCH, Gianaros PJ, Muldoon MF, Manuck SB. Use of total cerebral blood flow as an imaging biomarker of known cardiovascular risks. Stroke 2013;44:2480-2485.
14. Ryan JP, Sheu LK, Verstynen TD, Onyewuenyi IC, Gianaros PJ. Cerebral blood flow links insulin resistance and baroreflex sensitivity. PLoS One 2013;8:e83288.
15. Wang J, Alsop DC, Li L, et al. Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4. 0 tesla. Magn Reson Med 2002;48:242-254.
16. Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005;26:839-851.
17. Klunk WE, Price JC, Mathis CA, et al. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 2007;27: 6174-6184.
18. Benzinger TL, Blazey T, Jack CR Jr, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci USA 2013;110: E4502-E4509.
19. Fortea J, Sala-Llonch R, Bartrés-Faz D, et al. Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers. J Alzheimers Dis 2010;22: 909-922.
20. Ashford JW, Salehi A, Furst A, et al. Imaging the Alzheimer brain. J Alzheimers Dis 2011;26(suppl 3):1-27.
21. Ikonomovic MD, Klunk WE, Abrahamson EE, et al. Postmortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 2008;131: 1630-1645.
22. Chao LL, Buckley ST, Kornak J, et al. ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord 2010;24:19-27.
23. Kim S, Kim M, Rhee H, et al. Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele. Neuroradiology 2012;55:25-34.
24. Chen Y, Wolk DA, Reddin JS, et al. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology 2011;77:1977-1985.
25. Bateman RJ, Xiong C, Benzinger TLS, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012;367:795-804.
26. Kennedy AM, Newman SK, Frackowiak RS, et al. Chromosome 14 linked familial Alzheimer's disease: A clinico-pathological study of a single pedigree. Brain 1995;118:185-205.
27. Mosconi L, Sorbi S, de Leon MJ, et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med 2006;47:1778-1786.
28. Okonkwo OC, Xu G, Oh JM, et al. Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease. Cereb Cortex 2014;24:978-988.
29. Storandt M, Head D, Fagan AM, Holtzman DM, Morris JC. Toward a multifactorial model of Alzheimer disease. Neurobiol Aging 2012;33:2262-2271.